Sat, Apr 19, 2014, 10:16 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Spectrum Pharmaceuticals, Inc. Message Board

  • bjeslinger bjeslinger Jul 12, 2011 11:36 AM Flag

    AF Article oddly ignores SPPI

    "More Hot Biotech Trades for Second Half 2011

    The biotech stock trades listed on the following pages encompass pending FDA drug approval decisions and clinical trial results -- all of which have the potential to produce significant stock-price volatility in the next six months."

    In his article this morning AF neglected any mention of SPPI after opening with the above paragraph.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Oops, my mistake. SPPI was not listed in the header section but was listed in the article.

      "Spectrum Pharmaceuticals(SPPI_)
      The event: FDA decision to remove the bioscan requirement for Zevalin.
      The timeline: Nov. 20.
      The stakes: The use of Zevalin as a therapy for non-Hodgkin's lymphoma is hindered by an FDA-mandated "bioscan" requirement that doctors perform to predetermine the distribution of Zevalin throughout the body. Spectrum is seeking FDA permission to remove the bioscan requirementfrom the Zevalin label, which the company believes will make the drug easier to use along and also accelerate sales growth."

 
SPPI
6.74-0.14(-2.03%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT